Document is current

Article History

Received: 4 September 2017

Accepted: 1 March 2018

First Online: 13 March 2018

Authors’ information

: AA is a medical doctor undertaking general training for medical specialization; she contributed to this work as a medical student, integrated in the curricular unit of initiation to clinical research. CL and MAT are medical doctors specialized in Immunohemotherapy, with skills in flow cytometry; MAT has expertise in MDS immunophenotyping. AS is a medical doctor specialized in Immunohemoterapy, with skills in transfusion medicine. AM is a medical doctor specialized in Clinical Hematology, with expertise in cytogenetics. IF is a medical doctor specialized in Clinical Pathology, with skills in cytomorphology. JC is a medical doctor specialized in Clinical Hematology, head of the Department of Clinical Hematology, with a large experience in diagnosing and treating patients with MDS. ML is a medical doctor specialized in Immunohemotherapy, head of the flow cytometry laboratory, and an expert in flow cytometry applied to the diagnosis of hemato-oncological disorders.

: The study was approved by the Ethics Committee of Centro Hospitalar do Porto (Luísa Bernardo, medical doctor; Carla Teixeira, medical doctor; Fernanda Manuela, medical doctor; Paulina Aguiar, pharmacist; Paula Duarte, nurse; Maria Manuel Araújo Jorge, philosopher; and Jorge Andrade da Silva, jurist) and Hospital Research Coordination Office, and authorized by the Hospital Administration Board, being registered with the number 2015/123 (110-DEFI/075-CES). All patients and control subjects gave the informed consent prior to entering the study, and the procedures followed were in accordance with the Helsinki Declaration.

: Consent for publication was given in the informed consent to participate in the study.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.